Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, International, Randomised, Double-blind, Placebo Controlled Study to Demonstrate the Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

NCT02560948 is registered in ClinicalTrials.gov with BioTech Tools S.A. as lead sponsor.

NCT NCT02560948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, International, Randomised, Double-blind, Placebo Controlled Study to Demonstrate the Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Lead sponsor
BioTech Tools S.A.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2016
Enrollment
554 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hay fever